Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
University Of Exeter investment portfolio
University Of Exeter has made numerous investments in companies such as Mitorx Therapeutics, Neuronostics, and Attomarker within the Health Tech sector.
university
Portfolio
14
Team
0
Portfolio (14)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Attomarker Limited Attomarker develops nanophotonic biochemical testing platforms that provide rapid, multiplexed point‑of‑care measurement of multiple biomarkers in blood or saliva. Its diagnostics are aimed at healthcare professionals and patients for conditions such as COVID‑19, Long Covid, liver health, diabetes and antimicrobial resistance. | Healthcare & Life Sciences | Exeter | Confirmed | 2025-08-09 |
| Build Solar Ltd Build Solar Ltd creates “Solar Squared”, a building‑integrated photovoltaic system that generates electricity while providing thermal insulation and daylighting for walls, skylights and roofs. The product is marketed to the construction and building sector for integration into new and existing building envelopes. | Healthcare & Life Sciences | Truro | Confirmed | 2025-06-14 |
Shareholding changes (3)
University Of Exeter's positions across portfolio companies2025
- ORDINARY 0 → 30,000
2024
- ORDINARY 8,857 → 885,700
Articles (2)
- 25 Jun 2026
- 25 Apr 2026